Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Corcept Therapeutics Enters into Agreement with Quotient Clinical 11
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT122928 12
Corcept Therapeutics Enters into Agreement with Chiltern for CORT125134 13
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT125134 14
Licensing Agreements 15
Corcept Therapeutics Enters into Licensing Agreement with University of Chicago 15
Equity Offering 16
Corcept Therapeutics Raises USD17.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Corcept Therapeutics Completes Public Offering Of Common Stock For US$46.4 Million 17
Corcept Therapeutics Completes Private Placement Of Shares For US$12.4 Million Upon Exercise Of Warrants 18
Asset Transactions 19
Pharmakon Advisors Acquires Royalties Of Korlym From Corcept Therapeutics For Up To US$45 Million 19
Corcept Therapeutics Inc – Key Competitors 20
Corcept Therapeutics Inc – Key Employees 21
Corcept Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 01, 2018: Corcept Therapeutics announces third quarter 2018 financial results and provides corporate update 23
Aug 09, 2018: Corcept Therapeutics announces second quarter 2018 financial results and stock repurchase program; Provides clinical update 25
May 08, 2018: Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update 28
Feb 22, 2018: Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial 29
Feb 01, 2018: Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance 31
Nov 02, 2017: Corcept Therapeutics Announces Third Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update 32
Aug 01, 2017: Corcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update 33
May 01, 2017: Corcept Therapeutics Announces First Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update 34
Mar 06, 2017: Corcept Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance 35
Jan 30, 2017: Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 Financial Results 36
Jan 30, 2017: Corcept Therapeutics Annnounces Preliminary Fourth Quarter and Full-Year 2016 Financial Results and Corporate Update; Provides 2017 Revenue Guidance 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Corcept Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Corcept Therapeutics Enters into Agreement with Quotient Clinical 11
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT122928 12
Corcept Therapeutics Enters into Agreement with Chiltern for CORT125134 13
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT125134 14
Corcept Therapeutics Enters into Licensing Agreement with University of Chicago 15
Corcept Therapeutics Raises USD17.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Corcept Therapeutics Completes Public Offering Of Common Stock For US$46.4 Million 17
Corcept Therapeutics Completes Private Placement Of Shares For US$12.4 Million Upon Exercise Of Warrants 18
Pharmakon Advisors Acquires Royalties Of Korlym From Corcept Therapeutics For Up To US$45 Million 19
Corcept Therapeutics Inc, Key Competitors 20
Corcept Therapeutics Inc, Key Employees 21
Corcept Therapeutics Inc, Subsidiaries 22
List of Figures
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9